NBE Therapeutics AG

Suisse

 
Quantité totale PI 39
Rang # Quantité totale PI 36 552
Note d'activité PI 2,1/5.0    19
Rang # Activité PI 43 989
Classe Nice dominante Produits chimiques destinés à l'...

Brevets

Marques

17 1
7 0
13 0
1
 
Dernier brevet 2024 - Biocatalytical composition and u...
Premier brevet 2014 - Method of producing an immunolig...
Dernière marque 2019 - IADC
Première marque 2019 - iADC

Industrie (Classification de Nice)

Derniers inventions, produits et services

2022 Invention Human antibodies binding to ror2. The present invention relates to fully human antibodies and con...
Invention Method of producing an immunoligand/payload conjugate. The present invention relates to a method ...
Invention Biocatalytical composition and use for generation of immunoligand-payload conjugates. The presen...
Invention Biocatalytical composition and use for generation of immunoligand-payload conjugates. The present...
2021 Invention Ror1 antibody compositions and related methods. The invention provides antibodies, antibody drug...
Invention Binding protein drug conjugates comprising anthracycline derivatives. The present invention relat...
2020 Invention Anthracycline-based antibody drug conjugates having high in vivo tolerability. The present invent...
2019 Invention Sortase f and its use in methods for conjugation. The present invention relates to a method for ...
Invention Sortase f and its use in methods for conjugation. nnn motif, or a motif consisting of a mixture o...
Invention Binding protein-toxin conjugates comprising anthracyclines, and use thereof in immune-oncological...
P/S Active chemical ingredients for use in the manufacture of anti-cancer drugs; chemicals for use in...
P/S Active chemical ingredients for use in the manufacture of anti-cancer drugs, Chemical preparation...
2018 Invention Anthracycline-based antibody drug conjugates having high in vivo tolerability. The present ...
Invention Antibodies binding to a linear human cs1 epitope. An antibody or antigen-binding fragment thereof...
Invention Multispecific antibody product that binds to different ror1 epitopes. The present invention rela...
Invention Multispecific antibody product that binds to different ror1 epitopes. The present invention relat...
2017 Invention Ror1 antibody compositions and related methods. ROR1 Antibody Compositions and Related Methods Th...
2016 Invention Anti-ror1 antibodies. The present invention relates to a human or humanized antibody, or an antib...
Invention Anti-mesothelin antibodies. The present invention relates to a human or humanized antibody, or a...
Invention Anti-mesothelin antibodies. The present invention relates to a human or humanized antibody, or an...
Invention Maytansine-drug conjugates of her-2 specific binding proteins generated by site specific sortase-...
Invention Maytansine-drug conjugates of her- 2 specific binding proteins generated by site specific sortase...
2014 Invention Method of producing an immunoligand/payload conjugate. A method of producing an immunoligand/payl...
Invention Method of producing an immunoligan d/paylo ad conjugate by means of a sequence-specific transpept...